4743 (4743) News
Track canonical SquawkNews coverage tagged to 4743, 4743. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Oneness Biotech Co., Ltd. Advances SNS851 to Phase 1 MAD
Oneness Biotech advanced its siRNA candidate SNS851 to the multiple-ascending dose part of a Phase 1 trial after completing SAD in healthy volunteers; MAD will enroll participants with fatty liver disease, with data expe
NEWS | Sep 29, 2026, 12:01 PM UTC
L
Oneness Biotech Advances SNS851 to Phase 1 Multiple-Ascending Dose Evaluation for Obesity-Associated Metabolic Diseases
Oneness Biotech Co., Ltd., a Taiwan-based biotechnology company advancing innovative drugs for metabolic disorders, today announced completion of the single-ascending dose (SAD) portion (Part A) in healthy volunteers of
GEOPOLITICS | Sep 29, 2026, 12:01 PM UTC